Clinical Trials

42 enrolled

Other solid neoplasmThoracic

Leukemia, Lymphocytic, Chronic, B-Cell

NCT07510815 2026-04-06

DUAL-MESO-NK

Phase 1/2 Recruiting

36 enrolled

Mesothelioma, Malignant, Mesothelioma

NCT07502287 2026-03-30

DUAL-NK-NB

Phase 1/2 Recruiting

36 enrolled

CNSGastrointestinalSarcoma

Neuroblastoma, Recurrence, Ganglioneuroblastoma

NCT01804634 2026-03-13

Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Phase 2 Recruiting

60 enrolled

Neuroblastoma, Rhabdomyosarcoma, Sarcoma, Ewing, Osteosarcoma, Hepatoblastoma

NCT04697576 2026-03-10

Intralesional Influenza Vaccine for the Treatment of Stage I-IV Melanoma

Phase 1 Recruiting

36 enrolled

Dermatologic

Melanoma

NCT03501576 2026-02-11

Evaluation of Human Immune Responses Vaccination in Patients With Lymphoma

Recruiting

200 enrolled

Classical hematologyLymphoidMyeloidPlasma cell

Lymphoma, Follicular, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, T-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell

NCT05170399 2026-02-05

Vaccine Responses in Patients With B Cell Malignancies

Phase 4 Recruiting

500 enrolled

Lymphoid

Lymphoma

NCT06605625 2025-10-28

VRiC

Active not recruiting

250 enrolled

Influenza, Human

NCT03016806 2025-10-10

Umbilical Cord Blood Transplantation From Unrelated Donors

Recruiting

30 enrolled

Anemia, Aplastic, Immunologic Deficiency Syndromes, Lymphoma, Metabolic Diseases, Multiple Myeloma, Myelodysplastic Syndromes

NCT06664151 2025-10-02

A Phase 0 Window of Opportunity Trial of Intratumoral Seasonal Influenza Immunization in Cutaneous Squamous Cell Carcinoma (CSCC) Patients Awaiting Curative Excision

Phase EARLY_PHASE1 Recruiting

25 enrolled

Dermatologic

Skin Neoplasms

NCT07052422 2025-07-04

VEN+DAC+Bu2Flu4 vs Bu2Flu5 Conditioning Regimen for Elderly Myeloid Malignancies Undergoing Allo-HSCT

Phase 2/3 Not yet recruiting

160 enrolled

Other neoplasm

Older Patients

NCT03955991 2025-06-26

VSMART

Phase 4 Completed

109 enrolled

Breast

Breast Neoplasms, Influenza, Human

NCT06124131 2025-05-04

BENEFIT-C

Phase NA Completed

50 enrolled 15 charts

Vaccine-Preventable Diseases, COVID-19, Vaccination Hesitancy, Influenza, Human, Patient Acceptance of Health Care, Colorectal Neoplasms, Health Behavior

NCT04080531 2025-02-28

Influenza Vaccination for Flu Prevention in Patients With Plasma Cell Disorders

Phase 4 Completed

165 enrolled 9 charts

Plasma cell

Neoplasms, Plasma Cell

NCT02860039 2024-10-22

High Dose Flu Vaccine in Treating Children Who Have Undergone Donor Stem Cell Transplant

170 enrolled 11 charts

Influenza, Human, Neoplasms

NCT03061955 2024-10-04

Safety and Efficacy of Concurrent Administration of Influenza Vaccine in Patients Undergoing Anti-PD-1 Immunotherapy (Nivolumab, Pembrolizumab)

28 enrolled

Influenza, Human, Neoplasms

NCT05116917 2024-05-28

INFLUENCE

Phase 2 Terminated

19 enrolled

Influenza, Human, Pancreatic Neoplasms

NCT01949129 2024-01-16

Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia

Phase 2/3 Recruiting

1,800 enrolled

BreastDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05069935 2023-09-21

FT538 in Combination With Monoclonal Antibodies in Advanced Solid Tumors

Phase 1 Terminated

16 enrolled

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Esophageal Neoplasms, Carcinoma, Hepatocellular, Lung Neoplasms, Melanoma, Stomach Neoplasms, Carcinoma, Merkel Cell, Endometrial Neoplasms, Triple Negative Breast Neoplasms

NCT05395052 2023-09-21

FT536 Monotherapy and in Combination With Monoclonal Antibodies in Advanced Solid Tumors

Phase 1 Terminated

5 enrolled

BreastGastrointestinalGynecologicHead & NeckThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Colorectal Neoplasms

NCT05909423 2023-06-18

FLU-IMMUNE

Phase 2 Not yet recruiting

21 enrolled

Phase EARLY_PHASE1 Completed

Colorectal Neoplasms

NCT04484532 2023-06-06

Evaluation of Antibody Response to High-Dose Seasonal Influenza Vaccination in Patients With Myeloid Malignancy Receiving Chemotherapy and Healthy Volunteers

130 enrolled

MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT05322330 2023-02-09

Clinical Study of XPO-1 Inhibitors Plus CAR-T Cells in Relapsed Refractory B-cell Non-Hodgkin's Lymphoma

Phase 2 Unknown

20 enrolled

Lymphoid

Lymphoma, B-Cell

NCT02998736 2022-12-28

PERIOP-04

Phase 1 Completed

28 enrolled

Abdominal Cancer

NCT04591379 2022-12-13

Intratumoral Influenza Vaccine for Early Colorectal Cancer

10 enrolled

Colorectal Neoplasms

NCT02747407 2021-10-29

Qualitative, Qualitative, and Functional Studies Over the First Year in Measuring Immune System Response During the First Year of Therapy in Patients With Brain Tumors

55 enrolled

Phase EARLY_PHASE1 Unknown

Astrocytoma, Glioma, Oligodendroglioma

NCT04626752 2020-11-13

CAR-T Cells in Treating Patients With Relapsed or Refractory Multiple Myeloma

50 enrolled

Plasma cell

Multiple Myeloma, Recurrence

NCT04626765 2020-11-13

CAR-T for Children With Relapsed and Refractory Acute Lymphoblastic Leukemia

Phase EARLY_PHASE1 Unknown

50 enrolled

Other hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04221971 2020-10-01

NK Cell Infusion for Patients With Acute Myeloid Leukemia

Phase 1 Unknown

10 enrolled

Leukemia, Myeloid, Acute

NCT04355806 2020-04-21

Impact of Inactivated Trivalent Influenza Vaccine on NSCLC Patients Receiving PD-1 / PD-L1 Inhibitors

Unknown

160 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Influenza, Human

NCT01561989 2020-03-10

Cholecalciferol and Flu Vaccine in Treating Healthy Participants

Phase NA Terminated

11 enrolled 2 charts

Healthy, no Evidence of Disease

NCT03701438 2020-02-20

Immune Response to Influenza Vaccine in Adults With B-cell Malignancies Treated With Idelalisib

Terminated

2 enrolled

Lymphoid

B-cell Malignancies

NCT03590808 2019-09-19

Influenza Vaccination in Patients Receiving Immune Checkpoint Inhibitor

Phase NA Completed

143 enrolled

Influenza, Human

NCT02566265 2019-01-30

SHIVERING 2

122 enrolled 10 charts

LymphoidPlasma cell

Influenza, Human, Waldenstrom Macroglobulinemia, Multiple Myeloma

NCT01924169 2018-09-20

Lenalidomide as Immune Adjuvant in Patient's With Chronic Lymphocytic Leukemia (CLL)

Phase 2 Terminated

3 enrolled 7 charts

Agammaglobulinemia, Hematologic Diseases, Influenza, Human, Leukemia, Lymphocytic, Chronic, B-Cell

NCT01695733 2018-08-31

Response to Influenza Vaccine in Patients With Non-Hematologic Malignancies Receiving Chemotherapy

Phase 1 Terminated

21 enrolled

Tumor-Agnostic

Neoplasms

NCT01941758 2018-07-05

High-Dose Trivalent Influenza Vaccine in Inducing Immune Response Patients With Central Nervous System Tumors

Phase 1 Completed

28 enrolled

Central Nervous System Neoplasms

NCT01474174 2018-07-03

Trivalent Influenza Vaccine in Preventing Flu in Patients With Central Nervous System Tumors

38 enrolled

Other hematologic neoplasm

Central Nervous System Neoplasms

NCT01215981 2017-12-28

Influenza Vaccine Post Allogeneic Transplant

Phase NA Terminated

68 enrolled 6 charts

Influenza, Human, Hematologic Neoplasms

NCT00964821 2017-11-07

Flu Vaccine in Preventing Influenza Infection in Healthy Volunteers and in Patients Who Have Undergone Stem Cell Transplant